ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Evonik Industries’ nutrition and care business has struck a deal to manufacture, via fermentation, a mix of animal milk oligosaccharides developed by the start-up GNUbiotics. The companies say the product, AMObiome, can naturally restore the gut microbiota of cats, dogs, and livestock animals. In recent years, firms including BASF, DuPont, and Jennewein have commercialized human milk oligosaccharides for use in infant formula. In animals, the large sugar molecules can moderate infections from pathogens such as Escherichia coli and Salmonella, Evonik says.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X